Targeting CCR2 and CCR5 to inhibit macrophage/pulmonary artery smooth muscle cells cross-talk in pulmonary hypertension

A. Parpaleix (Creteil, France), S. Abid (Creteil, France), E. Marcos (Creteil, France), V. Amsellem (Creteil, France), A. Houssaïni (Creteil, France), M. Breau (Creteil, France), D. Sawaki (Creteil, France), E. Bizard (Creteil, France), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium), L. Lipskaia (Creteil, France), S. Adnot (Creteil, France)

Source: International Congress 2018 – Experimental research in pulmonary hypertension
Session: Experimental research in pulmonary hypertension
Session type: Thematic Poster
Number: 3066
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Parpaleix (Creteil, France), S. Abid (Creteil, France), E. Marcos (Creteil, France), V. Amsellem (Creteil, France), A. Houssaïni (Creteil, France), M. Breau (Creteil, France), D. Sawaki (Creteil, France), E. Bizard (Creteil, France), M. Delcroix (Leuven, Belgium), R. Quarck (Leuven, Belgium), L. Lipskaia (Creteil, France), S. Adnot (Creteil, France). Targeting CCR2 and CCR5 to inhibit macrophage/pulmonary artery smooth muscle cells cross-talk in pulmonary hypertension. 3066

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Endothelin-1 downregulates BMP signaling in pulmonary artery smooth muscle cells
Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments
Year: 2012

NMDA receptor crosstalk with PDGFR-β and BMPR2 is involved in smooth muscle cell proliferation in pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Increased expression of endothelinB receptors in the pulmonary arterial smooth muscle cells of fawn-hooded rat
Source: Eur Respir J 2001; 18: Suppl. 33, 416s
Year: 2001

Mir-17 modulates smooth muscle cell markers, apoptosis and BMPR-II levels in human pulmonary artery smooth muscle cells
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012

CCR2/CCR5-mediated macrophage–smooth muscle cell crosstalk in pulmonary hypertension
Source: Eur Respir J, 54 (4) 1802308; 10.1183/13993003.02308-2018
Year: 2019



CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Antiproliferative effects of drugs affecting different signalling pathways on rat and human pulmonary artery smooth muscle cells
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015

Hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: possible mechanisms
Source: Eur Respir J 2004; 24: Suppl. 48, 561s
Year: 2004

Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension
Source: Eur Respir J 2007; 29: 937-943
Year: 2007



miR 16 modulates human pulmonary artery smooth muscle cell phenotype
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012

The effect of ASK1 inhibition on hypoxia-induced pulmonary artery fibroblast activation and associated paracrine effects on vascular smooth muscle cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

LSC - 2018 - Pulmonary vascular remodeling mediated by ADORA2B in pulmonary artery smooth muscle cells
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018



Estrogen and progestin induce the migration of pulmonary artery smooth muscle cells with the contractile phenotype via different mechanisms
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021

Involvement of pulmonary artery smooth muscle cell apoptosis in simvastatin-induced regression of hypoxic pulmonary hypertension
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008


PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006


Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human pulmonary arterial smooth muscle cells
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008

Effect of endothelin-1 and bosentan on gene expressions in the cultured pulmonary artery smooth muscle cells
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010

Sildenafil modulates PDGF and Angiotensin II induced migration and proliferation in human pulmonary artery smooth muscle cells (PA-SMC)
Source: Eur Respir J 2002; 20: Suppl. 38, 227s
Year: 2002

Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery
Source: Eur Respir J 2001; 18: 5-14
Year: 2001